Status:
UNKNOWN
MultiOrgan Inflammatory Syndromes COVID-19 Related Study
Lead Sponsor:
Medical University of Warsaw
Collaborating Sponsors:
Wrocław Medical University
University of Warsaw
Conditions:
Covid19
Eligibility:
All Genders
Up to 18 years
Brief Summary
The study comprise a nationwide, voluntary, on-line survey of inflammatory syndromes in children for retrospective (since 4th March 2020) and prospective data collection. Our aim was to capture and de...
Detailed Description
The voluntary surveillance for retrospective (since 4th March) and prospective data collection was initiated under the National Consultant of Pediatrics auspices. Anonymized patient data from pediatri...
Eligibility Criteria
Inclusion
- patients who required hospitalization since 4th March 2020;
- diagnosed Kawasaki disease (KD) or incomplete (atypical) Kawasaki disease (aKD) or toxic shock syndrome (TSS) or macrophage activation syndrome (MAS) or unspecified inflammatory syndrome;
Exclusion
- other infectious and non-infectious causes that could be responsible for the disease
- SARS-CoV-2 polymerase chain reaction (PCR) or serology result could have been positive or negative. Due to limited availability and reliability of serologic testing, proven or likely COVID-19 criterion was not a condition determining inclusion to the registry.
Key Trial Info
Start Date :
May 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 25 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04811456
Start Date
May 25 2020
End Date
August 25 2025
Last Update
March 26 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Warsaw Children's Hospital
Warsaw, Poland, 02091
2
Wroclaw Medical University
Wroclaw, Poland, 50-368